ABZENA

abzena-logo

Abzena (AIM: ABZA) provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products, a growing area that requires specialist knowledge and expertise. The Group has a global customer base which includes the majority of the top 20 biopharmaceutical companies as well as large and small biotech companies and academic groups. The term “Abzena inside” is used by Abzena to describe products that have been created using its propr... ietary technologies and are being developed by its partners, and include Composite Human Antibodies™ and ThioBridge™ Antibody Drug Conjugates (ADCs). Abzena has the potential to earn future licence fees, milestone payments and/or royalties on “Abzena inside” products. Abzena offers the following services and technologies across its sites in Cambridge (UK), San Diego, California (USA) and Bristol, Pennsylvania (USA). •Immunogenicity assessment, protein engineering to create humanized antibodies and deimmunised therapeutic proteins, and cell line development for manufacture. •Contract process development and manufacture of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, vaccines, and gene therapy and cell therapy products, for preclinical and clinical studies. •Proprietary site-specific conjugation technologies for antibody drug conjugate development and solutions for optimizing the therapeutic properties of biopharmaceuticals. •Contract chemistry and bioconjugation business focused on ADCs and is establishing the capability to manufacture ADCs to GMP standards

#SimilarOrganizations #People #Financial #Event #Website #More

ABZENA

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2002-01-01

Address:
Cambridge, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.abzena.com

Total Employee:
101+

Status:
Active

Contact:
215-788-3603

Email Addresses:
[email protected]

Total Funding:
139.44 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Wordpress Plugins


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

immatics-biotechnologies-logo

immatics biotechnologies

immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

ksq-therapeutics-logo

KSQ Therapeutics

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

medigene-logo

MediGene

MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.


Current Advisors List

michelle-dipp_image

Michelle Dipp Board Member @ Abzena
Board_member
2020-06-01

Current Employees Featured

jonathan-goldman_image

Jonathan Goldman
Jonathan Goldman Chief Executive Officer & Founder @ Abzena
Chief Executive Officer & Founder
2018-10-01

michelle-neaves_image

Michelle Neaves
Michelle Neaves Head of Finance @ Abzena
Head of Finance
2016-10-01

sven-lee_image

Sven Lee
Sven Lee Chief Business Officer @ Abzena
Chief Business Officer
2016-10-01

campbell-bunce_image

Campbell Bunce
Campbell Bunce Senior Vice-President of Scientific Operations @ Abzena
Senior Vice-President of Scientific Operations
2015-11-01

kevin-lundquist_image

Kevin Lundquist
Kevin Lundquist CFO @ Abzena
CFO
2022-01-01

peter-gray_image

Peter Gray
Peter Gray Chairman @ Abzena
Chairman
2018-11-01

jim-kennamer_image

Jim Kennamer
Jim Kennamer SVP & Site Head- North Carolina @ Abzena
SVP & Site Head- North Carolina
2022-01-01

john-fikre_image

John Fikre
John Fikre General Counsel @ Abzena
General Counsel
2018-10-01

not_available_image

Alex Lazar
Alex Lazar Senior Director Analytical Method Development and QC @ Abzena
Senior Director Analytical Method Development and QC
2019-10-01

richard-millbank_image

Richard Millbank
Richard Millbank Chief Financial Officer @ Abzena
Chief Financial Officer

Founder


jonathan-goldman_image

Jonathan Goldman

Stock Details


Company's stock symbol is LSE:ABZA

Acquisitions List

Date Company Article Price
2015-11-24 The Chemistry Research Solution The Chemistry Research Solution acquired by Abzena N/A
2015-09-14 PacificGMP (now Abzena) PacificGMP (now Abzena) acquired by Abzena 7.7 M USD
2013-07-29 Antitope Ltd Antitope Ltd acquired by Abzena N/A
2013-07-29 PolyTherics PolyTherics acquired by Abzena N/A

Investors List

welsh-carson-anderson-stowe_image

Welsh Carson Anderson & Stowe

Welsh Carson Anderson & Stowe investment in Private Equity Round - Abzena

biospring-partners_image

Biospring Partners

Biospring Partners investment in Private Equity Round - Abzena

biospring-partners_image

Biospring Partners

Biospring Partners investment in Private Equity Round - Abzena

proven-vct_image

ProVen VCT

ProVen VCT investment in Post-IPO Equity - Abzena

catapult-venture-managers_image

Catapult Ventures

Catapult Ventures investment in Venture Round - Abzena

Key Employee Changes

Date New article
2022-01-21 Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina

Official Site Inspections

http://www.abzena.com Semrush global rank: 1.26 M Semrush visits lastest month: 23.61 K

  • Host name: 104.21.70.82
  • IP address: 104.21.70.82
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Abzena" on Search Engine